(UNVB) Unilever - Ratings and Ratios
Exchange: XETRA •
Country: United Kingdom •
Currency: EUR •
Type: Common Stock •
ISIN: GB00B10RZP78
Shampoo, Soap, Deodorant, Ice Cream, Seasoning
Dividends
| Dividend Yield | 3.67% |
| Yield on Cost 5y | 4.45% |
| Yield CAGR 5y | 0.25% |
| Payout Consistency | 97.8% |
| Payout Ratio | 73.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 16.9% |
| Value at Risk 5%th | 25.5% |
| Relative Tail Risk | -7.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.63 |
| Alpha | -12.05 |
| CAGR/Max DD | 0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.440 |
| Beta | -0.164 |
| Beta Downside | -0.194 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.60% |
| Mean DD | 5.82% |
| Median DD | 5.81% |
Description: UNVB Unilever December 11, 2025
Unilever PLC (XETRA: UNVB) is a global fast-moving consumer goods (FMCG) company that sells a diversified portfolio across five segments: Beauty & Wellbeing, Personal Care, Home Care, Foods, and Ice Cream. Its brands-including Dove, Axe, Hellmann’s, Knorr, Ben & Jerry’s, and Magnum-are marketed in the Asia-Pacific, Africa, the Americas, and Europe, covering everything from hair-care and oral-care products to detergents and frozen desserts.
Key recent metrics: FY 2023 reported net sales of €59.6 billion, with underlying growth of 4.5% driven primarily by emerging-market demand and price-adjustments. The company’s underlying operating margin slipped to 15.2% amid higher commodity and freight costs, while its “Sustainable Living” initiative targets a 50% reduction in carbon emissions by 2030. A sector-wide driver is the ongoing inflationary pressure on raw materials, which compresses margins for FMCG firms unless offset by pricing power or cost-efficiency programs.
For a deeper quantitative view of UNVB’s valuation and risk profile, you may find ValueRay’s analyst dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (11.13b TTM) > 0 and > 6% of Revenue (6% = 6.39b TTM) |
| FCFTA 0.14 (>2.0%) and ΔFCFTA -1.62pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -5.55% (prev -6.27%; Δ 0.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 12.59b > Net Income 11.13b (YES >=105%, WARN >=100%) |
| Net Debt (-4.34b) to EBITDA (21.56b) ratio: -0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.47b) change vs 12m ago -2.17% (target <= -2.0% for YES) |
| Gross Margin 68.63% (prev 16.63%; Δ 52.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 140.7% (prev 118.8%; Δ 21.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.18 (EBITDA TTM 21.56b / Interest Expense TTM 1.66b) >= 6 (WARN >= 3) |
Altman Z'' 4.27
| (A) -0.08 = (Total Current Assets 19.19b - Total Current Liabilities 25.10b) / Total Assets 76.00b |
| (B) 0.67 = Retained Earnings (Balance) 50.70b / Total Assets 76.00b |
| (C) 0.25 = EBIT TTM 18.60b / Avg Total Assets 75.63b |
| (D) 0.91 = Book Value of Equity 50.79b / Total Liabilities 56.07b |
| Total Rating: 4.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.94
| 1. Piotroski 7.0pt |
| 2. FCF Yield 7.56% |
| 3. FCF Margin 10.22% |
| 4. Debt/Equity 1.80 |
| 5. Debt/Ebitda -0.20 |
| 6. ROIC - WACC (= 43.33)% |
| 7. RoE 56.81% |
| 8. Rev. Trend 41.50% |
| 9. EPS Trend -21.50% |
What is the price of UNVB shares?
As of December 11, 2025, the stock is trading at EUR 55.26 with a total of 26,113 shares traded.
Over the past week, the price has changed by -3.87%, over one month by -6.69%, over three months by -7.23% and over the past year by -8.86%.
Over the past week, the price has changed by -3.87%, over one month by -6.69%, over three months by -7.23% and over the past year by -8.86%.
Is UNVB a buy, sell or hold?
Unilever has no consensus analysts rating.
What are the forecasts/targets for the UNVB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51.2 | -7.3% |
UNVB Fundamental Data Overview December 11, 2025
Market Cap USD = 136.31b (117.10b EUR * 1.164 EUR.USD)
Market Cap EUR = 117.10b (117.10b EUR * 1.0 EUR.EUR)
P/E Trailing = 21.3214
P/E Forward = 14.4509
P/S = 1.9592
P/B = 6.5807
P/EG = 1.588
Beta = 0.215
Revenue TTM = 106.45b EUR
EBIT TTM = 18.60b EUR
EBITDA TTM = 21.56b EUR
Long Term Debt = 23.29b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 7.16b EUR (from shortTermDebt, last quarter)
Debt = 32.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.34b EUR (from netDebt column, last quarter)
Enterprise Value = 143.82b EUR (117.10b + Debt 32.02b - CCE 5.31b)
Interest Coverage Ratio = 11.18 (Ebit TTM 18.60b / Interest Expense TTM 1.66b)
FCF Yield = 7.56% (FCF TTM 10.88b / Enterprise Value 143.82b)
FCF Margin = 10.22% (FCF TTM 10.88b / Revenue TTM 106.45b)
Net Margin = 10.46% (Net Income TTM 11.13b / Revenue TTM 106.45b)
Gross Margin = 68.63% ((Revenue TTM 106.45b - Cost of Revenue TTM 33.39b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 94.16%)
Tobins Q-Ratio = 1.89 (Enterprise Value 143.82b / Total Assets 76.00b)
Interest Expense / Debt = 1.70% (Interest Expense 545.8m / Debt 32.02b)
Taxrate = 25.17% (1.28b / 5.09b)
NOPAT = 13.92b (EBIT 18.60b * (1 - 25.17%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.10b)
Debt / Equity = 1.80 (Debt 32.02b / totalStockholderEquity, last quarter 17.80b)
Debt / EBITDA = -0.20 (Net Debt -4.34b / EBITDA 21.56b)
Debt / FCF = -0.40 (Net Debt -4.34b / FCF TTM 10.88b)
Total Stockholder Equity = 19.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.65% (Net Income 11.13b / Total Assets 76.00b)
RoE = 56.81% (Net Income TTM 11.13b / Total Stockholder Equity 19.60b)
RoCE = 43.37% (EBIT 18.60b / Capital Employed (Equity 19.60b + L.T.Debt 23.29b))
RoIC = 47.86% (NOPAT 13.92b / Invested Capital 29.09b)
WACC = 4.52% (E(117.10b)/V(149.13b) * Re(5.41%) + D(32.02b)/V(149.13b) * Rd(1.70%) * (1-Tc(0.25)))
Discount Rate = 5.41% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.09%
[DCF Debug] Terminal Value 78.42% ; FCFE base≈11.32b ; Y1≈11.43b ; Y5≈12.35b
Fair Price DCF = 88.94 (DCF Value 218.08b / Shares Outstanding 2.45b; 5y FCF grow 0.52% → 3.0% )
EPS Correlation: -21.50 | EPS CAGR: -50.20% | SUE: 0.0 | # QB: 0
Revenue Correlation: 41.50 | Revenue CAGR: 25.39% | SUE: N/A | # QB: 0
Market Cap EUR = 117.10b (117.10b EUR * 1.0 EUR.EUR)
P/E Trailing = 21.3214
P/E Forward = 14.4509
P/S = 1.9592
P/B = 6.5807
P/EG = 1.588
Beta = 0.215
Revenue TTM = 106.45b EUR
EBIT TTM = 18.60b EUR
EBITDA TTM = 21.56b EUR
Long Term Debt = 23.29b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 7.16b EUR (from shortTermDebt, last quarter)
Debt = 32.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.34b EUR (from netDebt column, last quarter)
Enterprise Value = 143.82b EUR (117.10b + Debt 32.02b - CCE 5.31b)
Interest Coverage Ratio = 11.18 (Ebit TTM 18.60b / Interest Expense TTM 1.66b)
FCF Yield = 7.56% (FCF TTM 10.88b / Enterprise Value 143.82b)
FCF Margin = 10.22% (FCF TTM 10.88b / Revenue TTM 106.45b)
Net Margin = 10.46% (Net Income TTM 11.13b / Revenue TTM 106.45b)
Gross Margin = 68.63% ((Revenue TTM 106.45b - Cost of Revenue TTM 33.39b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 94.16%)
Tobins Q-Ratio = 1.89 (Enterprise Value 143.82b / Total Assets 76.00b)
Interest Expense / Debt = 1.70% (Interest Expense 545.8m / Debt 32.02b)
Taxrate = 25.17% (1.28b / 5.09b)
NOPAT = 13.92b (EBIT 18.60b * (1 - 25.17%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.10b)
Debt / Equity = 1.80 (Debt 32.02b / totalStockholderEquity, last quarter 17.80b)
Debt / EBITDA = -0.20 (Net Debt -4.34b / EBITDA 21.56b)
Debt / FCF = -0.40 (Net Debt -4.34b / FCF TTM 10.88b)
Total Stockholder Equity = 19.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.65% (Net Income 11.13b / Total Assets 76.00b)
RoE = 56.81% (Net Income TTM 11.13b / Total Stockholder Equity 19.60b)
RoCE = 43.37% (EBIT 18.60b / Capital Employed (Equity 19.60b + L.T.Debt 23.29b))
RoIC = 47.86% (NOPAT 13.92b / Invested Capital 29.09b)
WACC = 4.52% (E(117.10b)/V(149.13b) * Re(5.41%) + D(32.02b)/V(149.13b) * Rd(1.70%) * (1-Tc(0.25)))
Discount Rate = 5.41% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.09%
[DCF Debug] Terminal Value 78.42% ; FCFE base≈11.32b ; Y1≈11.43b ; Y5≈12.35b
Fair Price DCF = 88.94 (DCF Value 218.08b / Shares Outstanding 2.45b; 5y FCF grow 0.52% → 3.0% )
EPS Correlation: -21.50 | EPS CAGR: -50.20% | SUE: 0.0 | # QB: 0
Revenue Correlation: 41.50 | Revenue CAGR: 25.39% | SUE: N/A | # QB: 0